The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming
Citations Over TimeTop 10% of 2015 papers
Abstract
Extensive reprogramming of cellular energy metabolism is a hallmark of cancer. Despite its importance, the molecular mechanism controlling this tumour metabolic shift remains not fully understood. Here we show that 14-3-3σ regulates cancer metabolic reprogramming and protects cells from tumorigenic transformation. 14-3-3σ opposes tumour-promoting metabolic programmes by enhancing c-Myc poly-ubiquitination and subsequent degradation. 14-3-3σ demonstrates the suppressive impact on cancer glycolysis, glutaminolysis, mitochondrial biogenesis and other major metabolic processes of tumours. Importantly, 14-3-3σ expression levels predict overall and recurrence-free survival rates, tumour glucose uptake and metabolic gene expression in breast cancer patients. Thus, these results highlight that 14-3-3σ is an important regulator of tumour metabolism, and loss of 14-3-3σ expression is critical for cancer metabolic reprogramming. We anticipate that pharmacologically elevating the function of 14-3-3σ in tumours could be a promising direction for targeted anticancer metabolism therapy development in future.
Related Papers
- → Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies(2020)177 cited
- → Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells(2010)85 cited
- → Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer(2020)33 cited
- → Pyruvate Kinase M2 Coordinates Metabolism Switch between Glycolysis and Glutaminolysis in Cancer Cells(2020)26 cited
- → Androgen Signaling Restricts Glutaminolysis to Drive Sex-Specific Th17 Metabolism(2023)